Perigord

What Perigord does

Perigord Life Science Solutions is a Dublin-headquartered, Tech Mahindra-majority-owned (70%, since 2021) provider of packaging artwork, labelling, and regulatory content services for the Life Sciences industry. The company operates exclusively within Life Sciences, serving pharmaceutical, biotech, medical device, veterinary, cosmeceutical, and nutraceutical clients, and claims relationships with 18 of the top 20 global pharmaceutical companies and over 400 customers worldwide.

Its core technology is the proprietary GLAMS (Global Life Sciences Automation Management Solutions) platform, which unifies artwork workflow management (AMS), regulatory change impact analysis (Impact Analysis), AI-powered brand governance (Periscope360), electronic product information (GLAMS ePI), and automation modules (Automation Manager, iCarton, iLeaflet). Perigord complements the platform with AI tools such as AmplifAI, VerifAI, and AceFin, and operates from certified Centres of Excellence holding PS 9000:2016, ISO 9001:2015, ISO 27001:2022, with compliance to 21 CFR Part 11, GMP/GxP, GDPR, and HIPAA.

The business model blends professional/managed services (artwork production, creative, brand strategy, business process outsourcing across clinical, regulatory, pharmacovigilance, and post-market) with recurring SaaS subscriptions on GLAMS. Go-to-market is direct enterprise field sales through regional offices in Ireland, Germany, the US (Branford, Boston, Sacramento), and India (Hyderabad), delivering 24/7 global launch support across 8 international sites with case-study volumes up to 18,000+ artworks annually for a single client.

Name

Perigord

Legal name

Perigord Asset Holdings Limited

Website

https://perigord-as.com

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

101–250 employees

Short description

Perigord Life Science Solutions provides regulated packaging artwork, labelling, and content management services for global pharmaceutical, biotech, and medical device companies. It serves 18 of the top 20 pharma firms via its proprietary GLAMS platform, AI-powered brand governance tools, and 24/7 global delivery centres.

Ownership category

akta.pro rank

Product category

Pharmaceutical Artwork Management

NAICS

Software Publishers (513210), Graphic Design Services (541430), Management, Scientific, and Technical Consulting Services (5416)

SIC

Services-Mailing, Reproduction, Commercial Art & Photography (7330)

akta.pro primary industry

Laboratory Quality & GLP/GCLP Compliance (HLAGAKAK)

Keywords

• Pharmaceutical artwork management
• Life sciences packaging solutions
• Regulatory labeling software
• Artwork production services
• Pharmaceutical packaging artwork

Headquarters

HQ city

Dublin

HQ country

Ireland

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Artwork Production Services: Fully outsourced artwork production services including creation, revision, and management of packaging artwork for global Life Sciences portfolios. Delivers high-volume artwork changes with validated processes.
2. Software Subscriptions (GLAMS Platform): SaaS-based artwork management system subscriptions providing validated workflow management, impact analysis, brand governance, and ePI capabilities. Operates on subscription model with configurable tiers.
3. Creative and Brand Services: Compliant creative solutions including brand strategy, design, medical copywriting, and omnichannel campaign development for Life Sciences organisations.
4. Business Process Services: Knowledge Process Outsourcing services including clinical services, regulatory affairs, pharmacovigilance, post-market services, and enterprise back-office services across Life Sciences value chain.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Perigord delivers fully outsourced artwork production, labelling, and content management services for global life sciences organisations, combined with its proprietary GLAMS software platform for artwork workflow management, regulatory change impact analysis, AI-powered brand governance, electronic product information, and automated artwork generation. The company serves pharmaceutical, biotech, medical device, veterinary, cosmeceutical, and nutraceutical clients with end-to-end capabilities spanning strategy, creative, technology, and operations.

Product overview

Perigord offers an integrated suite of life sciences packaging artwork and content management solutions built around the GLAMS (Global Life Sciences Automation Management Solutions) platform ecosystem. The core GLAMS AMS provides centralised artwork workflow management with version control and regulatory oversight, complemented by specialised modules: GLAMS Impact Analysis for automated regulatory change assessment, Periscope360 for AI-powered brand governance, GLAMS ePI for electronic product information management, and GLAMS Automation Manager with iCarton and iLeaflet extensions for automated artwork production from regulatory content sources. These products work together to streamline the complete artwork lifecycle from creation through approval, change management, and global deployment, with integrated automation capabilities that transform regulatory documents into production-ready packaging.

Differentiator

Problem solved

Functional benefit

Brands

• GLAMS: Global Life Sciences Automation Management Solutions - Artwork Management System platform for pharmaceutical, medical device, and biotech industries
• GLAMS AMS
• GLAMS Impact Analysis
• Periscope360
• GLAMS ePI
• iCarton
• iLeaflet
• AceFin
• CLEAR
• AmplifAI
• VerifAI

Products and services

• GLAMS AMS (Artwork Management System) Centralised artwork and labelling workflow management platform with full version control, traceability, and regulatory oversight, enabling global teams to collaborate on packaging artwork creation through approval and release for Life Sciences organisations.
• GLAMS Impact Analysis Automated regulatory change impact assessment tool that identifies affected SKUs, artworks, and components across packaging portfolios, visualising downstream impact of labelling or artwork changes before implementation for Life Sciences organisations.
• Periscope360 AI-powered brand governance platform that automatically verifies brand compliance across digital assets, ensuring consistent logos, fonts, colours, messaging, and global governance for Life Sciences brands.
• GLAMS ePI (Electronic Product Information) Structured electronic product information management platform enabling creation, management, and delivery of digital patient information aligned with emerging global ePI standards, connecting packaging artwork with regulatory data for Life Sciences organisations.
• GLAMS Automation Manager Automation module that ingests structured and unstructured regulatory content including Word documents, QRD templates, XML, and FHIR, preparing content for automated artwork production while maintaining regulatory traceability for Life Sciences organisations.
• iCarton Automated carton creation tool that connects structured regulatory content with Adobe Illustrator packaging templates, enabling rapid, consistent artwork generation while preserving approved layout structures and typography rules for Life Sciences packaging.
• iLeaflet InDesign extension that automates import and formatting of regulatory Word document content for patient information leaflet artwork, dramatically reducing manual formatting processes for complex regulatory documents in Life Sciences organisations.
• Artwork Production Services Fully outsourced artwork production services including creation, revision, and management of packaging artwork for global Life Sciences portfolios, delivering high-volume artwork changes with validated processes, 24/7 global production, and dedicated account teams.
• Creative and Brand Services Compliant creative solutions including brand strategy, design, medical copywriting, and omnichannel campaign development for Life Sciences organisations navigating regulated marketing communications.
• Business Process Services Knowledge Process Outsourcing services including clinical services, regulatory affairs, pharmacovigilance, post-market services, and enterprise back-office services across the Life Sciences value chain.
• Emerging Pharma Services Brand strategy, consultancy, and launch support services for emerging biotech and pharmaceutical companies preparing for first commercial success, including branding, packaging artwork foundation, regulatory navigation, and market preparation.

Quantifiable outcome

• 99% consistent accuracy in quality across operations
• +3 more outcomes

Named customers7 records

Segments7 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability7 records

Feature11 records

Scale indicators20 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Amplexor (now part of Accenture): Provides life sciences regulatory, quality, and content management services including labeling, artwork, and multilingual content—directly overlapping with Perigord's artwork production and GLAMS platform. Acquired by Accenture, giving it similar global delivery scale to Perigord/Tech Mahindra.
• RWS Group (formerly SDL): Global content and language services provider with a strong life sciences division covering regulatory content, translation, and IP-driven services. Competes with Perigord in regulated multilingual content and labeling production for pharma.
• PharmaLex (Cencora): Regulatory affairs, quality, and pharmacovigilance services provider for life sciences. Overlaps with Perigord's Business Process Services revenue stream and regulatory artwork offerings, especially in EU and US markets.
• TransPerfect Life Sciences: Provides language technology and content services specifically for pharma, biotech, and medical devices, including labeling translation and regulatory documentation. A direct competitor in the artwork/labeling production space for global pharma clients.
• PQE Group: Life sciences consulting firm specializing in regulatory compliance, quality, and engineering services for pharma, biotech, and medical devices. Competes with Perigord in regulatory affairs, GxP compliance, and validation work.

Broad incumbents

• Veeva Systems: Provides Veeva Vault, a leading cloud content and regulatory platform that competes with Perigord's GLAMS offering for artwork, labeling, and regulatory document management. A much larger, publicly traded incumbent with broader life sciences software reach.
• ICON plc: Global CRO and healthcare intelligence company with broad services including clinical, regulatory, and commercialization support. A broader incumbent that intersects with Perigord on regulatory and commercial artwork services for large pharma.
• Accenture Life Sciences: Global consulting and digital services giant with a dedicated life sciences practice including content, regulatory, and commercial operations. A broad incumbent that competes with Perigord for large enterprise content and compliance transformation mandates.
• DXC Technology (CSC Life Sciences heritage): Inherited life sciences content and regulatory services capabilities from CSC (incl. Opti-Lynx and global life sciences practice). Provides enterprise content management, regulatory, and quality services overlapping with Perigord's regulated content offerings.

Emerging players

• ArisGlobal: Life sciences technology vendor offering regulatory, safety (pharmacovigilance), and clinical software platforms. Overlaps with Perigord's GLAMS and BPO pharmacovigilance offerings, though primarily a software player rather than services-led.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/perigord
• Xx.com/Perigord_AS

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Perigord